These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2878318)

  • 1. Risk/benefit of heparin-dihydroergotamine thromboembolic prophylaxis.
    Schlag G; Poigenfürst J; Gaudernak T
    Lancet; 1986 Dec 20-27; 2(8521-22):1465. PubMed ID: 2878318
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis of postoperative thromboembolism with low dose heparin alone or in combination with dihydroergotamine. A review.
    Lindblad B
    Acta Chir Scand Suppl; 1988; 543():31-42. PubMed ID: 3055779
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of postoperative thrombo-embolism by heparin/dihydroergotamine (author's transl].
    Koppenhagen K; Wiechmann A; Frey E; Wenig HG; Latka H; Zühlke HV; Tank E; Hardieck J; Ernst H; Häring R
    Dtsch Med Wochenschr; 1977 Sep; 102(39):1374-8. PubMed ID: 334500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perioperative prevention of thromboembolism with low molecular weight heparin and postoperative bleeding complications].
    Hoffman R; Largiadèr F; Brütsch HP
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():1179-84. PubMed ID: 1983509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complications in drug prevention of thromboembolism].
    Tittel K
    Unfallchirurgie; 1985 Jun; 11(3):150-5. PubMed ID: 4035815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ergotism within the scope of the postoperative prevention of thromboembolism].
    Kneist W; Heesen U; Assmann H
    Zentralbl Chir; 1987; 112(22):1426-35. PubMed ID: 3439378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement.
    J Bone Joint Surg Am; 1989 Feb; 71(2):311-2. PubMed ID: 2918019
    [No Abstract]   [Full Text] [Related]  

  • 8. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboembolism after hip surgery.
    Westermann K; Trentz O; Pretschner P; Mellmann J
    Int Orthop; 1981; 4(4):253-7. PubMed ID: 6164655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative assessment of drug-induced prophylaxis of postoperative thromboembolism. Comparison of frequencies of deep vein thrombosis and pulmonary embolism using acetylsalicylic-acid, dextran, dihydroergotamine, low-dose heparin and the fixed combination of heparin and dihydroergotamine (author's transl)].
    Buttermann G; Theisinger W; Weidenbach A; Hartung R; Welzel D; Pabst HW
    Med Klin; 1977 Oct; 72(40):1624-38. PubMed ID: 916947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peroperative thromboembolism prophylaxis: low-dose heparin or low molecular weight heparin-DHE, the advantages and disadvantages. A prospective randomized study].
    Hoffmann R; Largiadèr F; Roethlin M
    Helv Chir Acta; 1987 Dec; 54(4):521-5. PubMed ID: 2833477
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylaxis of postoperative thromboembolism: low dose heparin versus heparin plus dihydroergotamine.
    Brücke P; Dienstl E; Vinazzer H; Simma W
    Thromb Res; 1983 Feb; 29(3):377-82. PubMed ID: 6845285
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic advances in thromboembolic disease. I. Dihydroergotamine + heparin].
    de Diego I; Jané F; Félez J
    Sangre (Barc); 1981; 26(4):471-83. PubMed ID: 7027494
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic efficacy of low-dose dihydroergotamine and heparin in postoperative deep venous thrombosis following intra-abdominal operations.
    J Vasc Surg; 1984 Sep; 1(5):608-16. PubMed ID: 6389909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of dihydroergotamine and heparin in the prophylaxis of deep venous thrombosis.
    Comerota AJ; White JV
    Chest; 1986 May; 89(5 Suppl):389S-395S. PubMed ID: 3698718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of thromboembolism with heparin and dihydroergotamine in a trauma surgery patient sample--comparison of the effectiveness of different administration forms of dihydroergotamine].
    Schott G; Elsel W; Möckel G; Rothe G
    Z Arztl Fortbild (Jena); 1992 Oct; 86(19):973-6. PubMed ID: 1441633
    [No Abstract]   [Full Text] [Related]  

  • 17. [Control of venous stasis. Use of low molecular weight heparin--a multicenter study].
    Kreutzberg K
    Fortschr Med; 1988 Sep; 106(27):67. PubMed ID: 3053377
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute ischemia due to vasospasm following prevention of thrombosis with dihydroergotamine/heparin].
    Meybier H; Krämer KL; Maeder N; Kretzschmar U; Allenberg JR
    Rontgenpraxis; 1987 Aug; 40(8):287-94. PubMed ID: 3660102
    [No Abstract]   [Full Text] [Related]  

  • 19. Ergotism as complication of thromboembolic prophylaxis with heparin and dihydroergotamine.
    Gatterer R
    Lancet; 1986 Sep; 2(8507):638-9. PubMed ID: 2875358
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prevention of thromboembolism in accident surgery--angiospastic complications with DHE-heparin. A multicenter study].
    Gatterer R; Wruhs O; Havelec L; Polterauer P; Marosi L
    Unfallchirurgie; 1987 Oct; 13(5):263-70. PubMed ID: 3321657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.